Risk of Progression to Kidney Failure in IgA Nephropathy
This infographic highlights the risk of progression to ESKD, including in patients traditionally considered low risk. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Subtopics
APRIL & the 4-Hit Pathogenic Cascade of IgAN
This infographic highlights the role of APRIL in a pre-hit 1 step that drives the 4-hit cascade.1 References 1. Mathur M, et al. J Clin Med. 2023;12(21):6927. Read MoreKey Messages from KDIGO IgAN Experts (2025)
These videos are part of a three-part series featuring IgA Nephropathy (IgAN) experts and Work Group Members of the forthcoming KDIGO 2025 IgAN Guideline Update sharing key insights on emerging… Read MoreTransition of Care from Pediatric to Adult Nephrology Webinar
During this webinar, Dr. McCune and Dr. Greco will discuss the process of transitioning from pediatric to adult nephrology care. They will discuss the process and best practices associates with… Read MoreTransition From Adult to Pediatric Nephrology Care
Learn about challenges and tips for success associated with the transition from pediatric to adult nephrology care. Read MoreHot Topics in Nephrology: An Update in Xenotransplantation & Confirmation of the new Administrator for the Centers for Medicare & Medicaid Services (CMS)
The world’s longest-lasting pig kidney transplant was removed from the human recipient Friday April 4th 2025, marking the end of the longest lasting xenotransplantation to date. Read MoreFrom Diagnosis to Management in IgA Nephropathy: How Health Literacy Shapes the Patient Journey
Learn about health literacy and how it impacts patients with CKD including IgAN. Dr. Velez will share her expertise as a nephrologist treating patients with IgAN as well as discuss… Read MoreKey Takeaways for Clinicians from the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, & Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This is the first guideline from KDIGO on a rare kidney disease, and provides healthcare providers, stakeholders, and people living with ADPKD with practical tools to improve diagnosis, care, and… Read MoreHot Topics in Nephrology: Updates on the Federal Nomination Process & the Utility of the Transplant Wait List
In 2024, patients on the waiting lists for nearly 20 percent of transplants from deceased donors were skipped over in favor for someone further down the list. This is six… Read MoreHot Topics in Nephrology: Potential Cuts to National Institutes of Health on Medical Research Fees & More Details from the Results of the Kidney Care Choices Model (KCC)
The National Institutes of Health (NIH) awards grants providing federal funding for research purposes, including payments for “indirect costs,” defined as “facilities” and “administration.” Previously these were negotiated indirect cost… Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
